» Articles » PMID: 27575935

Wnt3A Induces GSK-3β Phosphorylation and β-Catenin Accumulation Through RhoA/ROCK

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2016 Aug 31
PMID 27575935
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

In canonical pathway, Wnt3A has been known to stabilize β-catenin through the dissociation between β-catenin and glycogen synthase kinase-3β (GSK-3β) that suppresses the phosphorylation and degradation of β-catenin. In non-canonical signaling pathway, Wnt was known to activate Rho GTPases and to induce cell migration. The cross-talk between canonical and non-canonical pathways by Wnt signaling; however, has not been fully elucidated. Here, we revealed that Wnt3A induces not only the phosphorylation of GSK-3β and accumulation of β-catenin but also RhoA activation in RAW264.7 and HEK293 cells. Notably, sh-RhoA and Tat-C3 abolished both the phosphorylation of GSK-3β and accumulation of β-catenin. Y27632, an inhibitor of Rho-associated coiled coil kinase (ROCK) and si-ROCK inhibited both GSK-3β phosphorylation and β-catenin accumulation. Furthermore, active domain of ROCK directly phosphorylated the purified recombinant GSK-3β in vitro. In addition, Wnt3A-induced cell proliferation and migration, which were inhibited by Tat-C3 and Y27632. Taken together, we propose the cross-talk between canonical and non-canonical signaling pathways of Wnt3A, which induces GSK-3β phosphorylation and β-catenin accumulation through RhoA and ROCK activation. J. Cell. Physiol. 232: 1104-1113, 2017. © 2016 Wiley Periodicals, Inc.

Citing Articles

In Vitro Gene Therapy Using Human iPS-Derived Mesoangioblast-Like Cells (HIDEMs) Combined with Microdystrophin () Expression as the New Strategy for Duchenne Muscular Dystrophy (DMD) Experimental Treatment.

Budzinska M, Malcher A, Zimna A, Kurpisz M Int J Mol Sci. 2024; 25(22).

PMID: 39595938 PMC: 11593506. DOI: 10.3390/ijms252211869.


Y-27632 targeting ROCK1&2 modulates cell growth, fibrosis and epithelial-mesenchymal transition in hyperplastic prostate by inhibiting β-catenin pathway.

Shan S, Su M, Wang H, Guo F, Li Y, Zhou Y Mol Biomed. 2024; 5(1):52.

PMID: 39455522 PMC: 11511810. DOI: 10.1186/s43556-024-00216-9.


LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer.

Mehdawi L, Ghatak S, Chakraborty P, Sjolander A, Andersson T Cells. 2023; 12(22).

PMID: 37998393 PMC: 10670301. DOI: 10.3390/cells12222658.


Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles.

Shan S, Su M, Li Y, Wang Z, Liu D, Zhou Y Mol Med. 2023; 29(1):139.

PMID: 37864185 PMC: 10589999. DOI: 10.1186/s10020-023-00734-2.


The Wnt/β-catenin signaling pathway inhibits osteoporosis by regulating the expression of TERT: an in vivo and in vitro study.

Cai Y, Sun H, Song X, Zhao J, Xu D, Liu M Aging (Albany NY). 2023; 15(20):11471-11488.

PMID: 37862118 PMC: 10637795. DOI: 10.18632/aging.205136.